Company Details
thecenterforbiosimilars
2
16,825
511
centerforbiosimilars.com
0
THE_3348741
In-progress

The Center for Biosimilars Company CyberSecurity Posture
centerforbiosimilars.comHealth economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.
Company Details
thecenterforbiosimilars
2
16,825
511
centerforbiosimilars.com
0
THE_3348741
In-progress
Between 700 and 749

CB Global Score (TPRM)XXXX

Description: MJH Life Sciences (“MJH”) reported a data breach with the Attorney General of Massachusetts. While MJH Life Sciences has not confirmed what types of information were compromised. Social Security numbers, protected health information, or financial account information were compromised. MJH Life Sciences sent out data breach letters to all affected parties.
Description: On November 26, 2018, the California Office of the Attorney General reported a data breach involving Pharmacy Times Office of Continuing Professional Education, LLC (PTCE) that occurred on July 6, 2018. The breach may have involved unauthorized access to a file containing personally identifiable information that was publicly accessible between May 11, 2018, and July 6, 2018. The number of individuals affected is reported to be 804 in total.


No incidents recorded for The Center for Biosimilars in 2025.
No incidents recorded for The Center for Biosimilars in 2025.
No incidents recorded for The Center for Biosimilars in 2025.
CB cyber incidents detection timeline including parent company and subsidiaries

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.


Massage Envy is the nation’s #1 provider of massage collectively across its franchise network and a national leader in skin care. All Massage Envy locations are independently owned and operated franchises, where the franchisee is the sole employer of all positions. Massage Envy combines big-brand r

Here at Aetna, a CVS Health® company, we’re building a healthier world by making health care easy, affordable and all about you. Because Healthier Happens Together™! Follow our page for company news, industry commentary, jobs and more. Founded in 1853 in Hartford, CT, Aetna® is one of the nation's l

Herbalife is a global health and wellness community born to support you in living your best life. For over 40 years and in more than 90 countries, we’ve empowered millions of people to make real changes to their lives with our science-backed products, the support of a coach – what we call an Herbali
LA Fitness is a privately owned fitness club chain. LA Fitness has hundreds of health clubs gyms and millions of members across US and Canada. In an industry often equated with fad and fashion, LA Fitness has steadily increased its presence by focusing on the one lifelong benefit valued by everyone:
Life Time provides an entertaining, educational, friendly and inviting, functional and innovative experience of uncompromising quality that meets the health and fitness needs of the entire family. Life Time is a wellness pioneer reshaping the way consumers approach their health by integrating where

Welcome to the American Heart Association’s movement to change the future of health and be the progress that ensures longer, healthier lives for all. By driving breakthroughs in science, policy, and care – together -- we can overcome today’s biggest health challenges and transform lives every day.
.png)
A small village in Hamilton County is weighing its options after its computer systems were hacked for ransom.
South Korean solar inverter makers have jointly launched a new association of inverter manufacturers to coordinate domestic production,...
By Apoorva Chhabra. CIOs often struggle to convey the true value of cybersecurity to their organizations and secure buy-in from C-suite...
GOLF MANOR, Ohio (WKRC) - The Village of Golf Manor is dealing with ransomware from a cybersecurity breach. At the Nov.
In recent years, cyber-attacks have largely centered on state-sponsored hacking groups and independent cyber-criminals breaching private companies,...
"API is a huge threat landscape at this point. There's no avoiding it with the connected vehicle," said Joshua Poster,...
Press release - Getnews - Fortem Cybersecurity, the New Global Cybersecurity Brand from Maguen Group, Officially Launches - published on...
Before machines take the lead, Mexican companies must get their processes, their data, and their cybersecurity in order, writes Carolina...
Manufacturers looking to enter the European Union market must understand and are required to implement Cyber Resilience Act requirements.

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of The Center for Biosimilars is http://www.centerforbiosimilars.com.
According to Rankiteo, The Center for Biosimilars’s AI-generated cybersecurity score is 749, reflecting their Moderate security posture.
According to Rankiteo, The Center for Biosimilars currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, The Center for Biosimilars is not certified under SOC 2 Type 1.
According to Rankiteo, The Center for Biosimilars does not hold a SOC 2 Type 2 certification.
According to Rankiteo, The Center for Biosimilars is not listed as GDPR compliant.
According to Rankiteo, The Center for Biosimilars does not currently maintain PCI DSS compliance.
According to Rankiteo, The Center for Biosimilars is not compliant with HIPAA regulations.
According to Rankiteo,The Center for Biosimilars is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
The Center for Biosimilars operates primarily in the Book and Periodical Publishing industry.
The Center for Biosimilars employs approximately 2 people worldwide.
The Center for Biosimilars presently has no subsidiaries across any sectors.
The Center for Biosimilars’s official LinkedIn profile has approximately 16,825 followers.
No, The Center for Biosimilars does not have a profile on Crunchbase.
Yes, The Center for Biosimilars maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/thecenterforbiosimilars.
As of November 28, 2025, Rankiteo reports that The Center for Biosimilars has experienced 2 cybersecurity incidents.
The Center for Biosimilars has an estimated 4,881 peer or competitor companies worldwide.
Incident Types: The types of cybersecurity incidents that have occurred include Breach and Cyber Attack.
Detection and Response: The company detects and responds to cybersecurity incidents through an communication strategy with data breach letters sent to all affected parties..
Title: MJH Life Sciences Data Breach
Description: MJH Life Sciences reported a data breach with the Attorney General of Massachusetts. While MJH Life Sciences has not confirmed what types of information were compromised, Social Security numbers, protected health information, or financial account information were compromised. MJH Life Sciences sent out data breach letters to all affected parties.
Type: Data Breach
Title: Data Breach at Pharmacy Times Office of Continuing Professional Education, LLC
Description: Unauthorized access to a file containing personally identifiable information that was publicly accessible between May 11, 2018, and July 6, 2018.
Date Detected: 2018-07-06
Date Publicly Disclosed: 2018-11-26
Type: Data Breach
Attack Vector: Unauthorized Access
Common Attack Types: The most common types of attacks the company has faced is Cyber Attack.

Data Compromised: Social security numbers, Protected health information, Financial account information

Data Compromised: Personally identifiable information
Commonly Compromised Data Types: The types of data most commonly compromised in incidents are Social Security Numbers, Protected Health Information, Financial Account Information, and Personally Identifiable Information.

Entity Name: MJH Life Sciences
Entity Type: Company
Industry: Life Sciences

Entity Name: Pharmacy Times Office of Continuing Professional Education, LLC
Entity Type: Company
Industry: Healthcare
Customers Affected: 804

Communication Strategy: Data breach letters sent to all affected parties

Type of Data Compromised: Social security numbers, Protected health information, Financial account information
Sensitivity of Data: High
Personally Identifiable Information: Social Security numbers

Type of Data Compromised: Personally Identifiable Information
Number of Records Exposed: 804

Regulatory Notifications: Reported to the Attorney General of Massachusetts

Source: California Office of the Attorney General
Date Accessed: 2018-11-26
Additional Resources: Stakeholders can find additional resources on cybersecurity best practices at and Source: California Office of the Attorney GeneralDate Accessed: 2018-11-26.
Communication of Investigation Status: The company communicates the status of incident investigations to stakeholders through Data breach letters sent to all affected parties.

Customer Advisories: Data breach letters sent to all affected parties
Advisories Provided: The company provides the following advisories to stakeholders and customers following an incident: was Data breach letters sent to all affected parties.
Most Recent Incident Detected: The most recent incident detected was on 2018-07-06.
Most Recent Incident Publicly Disclosed: The most recent incident publicly disclosed was on 2018-11-26.
Most Significant Data Compromised: The most significant data compromised in an incident were Social Security numbers, protected health information, financial account information, , Personally Identifiable Information and .
Most Sensitive Data Compromised: The most sensitive data compromised in a breach were Social Security numbers, Personally Identifiable Information, financial account information and protected health information.
Number of Records Exposed in Most Significant Breach: The number of records exposed in the most significant breach was 804.0.
Most Recent Source: The most recent source of information about an incident is California Office of the Attorney General.
Most Recent Customer Advisory: The most recent customer advisory issued was an Data breach letters sent to all affected parties.
.png)
ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.
Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).
Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint
Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.
Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.